PCI Pharma Services Acquires Ajinomoto Althea

PCI Pharma Services Acquires Lyophilization Services of New England (LSNE)

October 12, 2021

Pharmaceuticals

PCI Pharma Services (PCI) has acquired Lyophilization Services of New England, Inc. (LSNE), a Bedford, New Hampshire–based CDMO, from private equity firm Permira. The deal expands PCI’s global sterile fill-finish and lyophilization capabilities, adding five FDA-approved facilities (U.S. and Spain) and strengthening its end-to-end manufacturing offering for biologics and injectables.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Kohlberg & Mubadala Acquire Majority Stake in PCI Pharma Services

December 1, 2020

Healthcare Services

Private equity firm Kohlberg & Company acquired a majority stake in PCI Pharma Services, with Mubadala Investment Company joining as a significant investor and Partners Group retaining a minority stake. The deal (signed August 24, 2020 and closed December 1, 2020) positions PCI to expand capabilities—such as sterile fill/finish and high-potency manufacturing—and further geographic reach while continuing to serve pharmaceutical and biopharmaceutical customers from its Philadelphia headquarters.

Bain Capital and Kohlberg Lead Strategic Investment in PCI Pharma Services

July 14, 2025

Healthcare Services

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), received a strategic growth investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala and a continuing minority stake from Partners Group. The capital will be used to accelerate PCI's organic and inorganic growth, expand sterile fill-finish and specialized manufacturing capacity, and broaden its geographic footprint to support biopharma customers and U.S. pharmaceutical supply-chain resilience.

Alcami Corporation Acquires Pacific Pharmaceutical Services

January 17, 2024

Healthcare Services

Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.

Sterling Pharma Solutions Acquires Alcami's Germantown (WI) API Facility

October 1, 2020

Pharmaceuticals

Sterling Pharma Solutions, a portfolio company of GHO Capital Partners, has acquired Alcami’s Germantown, Wisconsin API development and manufacturing facility. The facility expands Sterling’s US footprint and adds cGMP capacity for complex and hazardous API projects, including plant-scale hydrogenation and cryogenic reactions.